Merck CEO Stresses Need For ‘Fair Return’ On COVID-19 Interventions
Also Shares Views On US Pricing Moves
Merck & Co’s chief executive shares views on the need for “reasonable” returns on COVID-19 therapeutics and vaccines, and on the future US pricing environment, at the USAIC summit.
